Abstract
Invasive aspergillosis of the central nervous system has a mortality rate exceeding 90%. We describe a 29-year-old woman with a medical history of chronic polyarthritis who developed a proven rhinocerebral Aspergillus fumigatus infection refractory to first-line treatment with liposomal amphotericin B. The patient responded successfully to salvage combination treatment with voriconazole and caspofungin. Furthermore, for the first time, voriconazole levels in an intracerebral abscess were measured in this patient undergoing voriconazole oral therapy.
| Original language | English |
|---|---|
| Journal | International Journal of Antimicrobial Agents |
| Volume | 28 |
| Issue number | 3 |
| Pages (from-to) | 262-265 |
| Number of pages | 4 |
| ISSN | 0924-8579 |
| DOIs | |
| Publication status | Published - 09.2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver